We demonstrate here that over-expression of aberrant MUC1 glycoform amplifies the inflammatory signal induced by AOM/DSS treatment and establishes a positive regulation of inflammatory cytokines, mediated by p65 and EzH2, which positively controls tumor growth and progression. The gene discussed is EZH2; the disease is neoplasm.